{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:55Z","timestamp":1786119535978,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Family planning and contraception are central to disease management in people with rheumatic musculoskeletal diseases (RMD), particularly systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), in whom unplanned pregnancy can carry substantial maternal and fetal risk. This review summarizes current evidence and guideline-based recommendations regarding contraceptive choices in women with SLE and APS, with a focus on thrombotic risk, bone health, and cardiovascular considerations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Estrogen-containing hormonal contraception is well established as a pro-thrombotic risk and should be avoided in those with APS, antiphospholipid antibodies (aPL), lupus nephritis, or at least moderately active SLE. Emerging data also suggest an association of certain higher dose progestins such as norethindrone acetate, and injectable preparations such as depot medroxyprogesterone acetate (DMPA), with increased venous thromboembolism (VTE) risk. Regarding bone health, oral contraceptive pills (OCPs) and combined hormonal contraception (CHC) may slow the rate of bone mass acquisition in adolescents with uncertain long-term effects on fracture risk, whereas use in adult women is associated with modestly higher bone mineral density and lower osteoporotic risk. While awareness of the importance of contraception in the rheumatology community is improving, real-world practice reveals that implementation of reproductive health guidelines is lagging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>For women with SLE and APS, contraception selection must account for thrombotic risk, bone health, and cardiovascular comorbidities. Long-acting reversible contraceptives, particularly progestin-only intrauterine devices (IUDs) and subdermal implants, remain highly effective and well tolerated for those with SLE and APS. Ongoing efforts to improve guideline implementation, shared decision-making, and patient and provider education are essential to reduce unplanned pregnancies and optimize reproductive outcomes in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000001162","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:00:41Z","timestamp":1777363241000},"page":"297-303","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Contraception in systemic lupus erythematosus and antiphospholipid antibody syndrome"],"prefix":"10.1097","volume":"38","author":[{"given":"Lauren","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Marder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"R1-20260528","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R2-20260528","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R3-20260528","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2215\/CJN.00240110","article-title":"A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis","volume":"5","author":"Smyth","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R5-20260528","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.contraception.2014.04.001","article-title":"Side effects unrelated to disease activity and acceptability of highly effective contraceptive methods in women with systemic lupus erythematosus: a randomized, clinical trial","volume":"90","author":"Cravioto","year":"2014","journal-title":"Contraception"},{"key":"R6-20260528","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-0044-1790225","article-title":"Impact of antiphospholipid syndrome on reproductive outcomes: current insights and management approaches","volume":"42","author":"He","year":"2024","journal-title":"Semin Reprod Med"},{"key":"R7-20260528","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1182\/hematology.2024000591","article-title":"Estrogen, progestin, and beyond: thrombotic risk and contraceptive choices","volume":"2024","author":"Skeith","year":"2024","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"R8-20260528","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0049-3848(13)70009-4","article-title":"Mechanisms of hormonal therapy related thrombosis","volume":"131","author":"Sandset","year":"2013","journal-title":"Thromb Res"},{"key":"R9-20260528","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/AOG.0000000000004896","article-title":"Association of progestogens and venous thromboembolism among women of reproductive age","volume":"140","author":"Cockrum","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R10-20260528","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"R11-20260528","doi-asserted-by":"crossref","first-page":"keaf464","DOI":"10.1093\/rheumatology\/keaf464","article-title":"Venous thromboembolism in patients with lupus nephritis: frequency and risk factors\u2014a cohort study","volume":"65","author":"Kharouf","year":"2026","journal-title":"Rheumatology (Oxford)"},{"key":"R12-20260528","doi-asserted-by":"crossref","first-page":"111207","DOI":"10.1016\/j.contraception.2025.111207","article-title":"Safety and effectiveness of contraception among women with chronic kidney disease: a systematic review","volume":"1","author":"Kortsmit","year":"2025","journal-title":"Contraception"},{"key":"R13-20260528","doi-asserted-by":"crossref","first-page":"111015","DOI":"10.1016\/j.contraception.2025.111015","article-title":"Using updated clinical recommendations to support contraceptive decision-making: U.S. medical eligibility criteria for contraceptive use, 2024","volume":"1","author":"Curtis","year":"2025","journal-title":"Contraception"},{"key":"R14-20260528","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/acr.24346","article-title":"Racial differences in contraception encounters and dispensing among female Medicaid beneficiaries with systemic lupus erythematosus","volume":"73","author":"Williams","year":"2021","journal-title":"Arthritis Care Res"},{"key":"R15-20260528","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1007\/s00198-017-4189-7","article-title":"Inflammatory diseases and bone fragility","volume":"28","author":"Briot","year":"2017","journal-title":"Osteoporos Int"},{"key":"R16-20260528","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.maturitas.2021.11.013","article-title":"Menstrual irregularity and bone health in premenopausal women: are oral contraceptives the best option?","volume":"155","author":"Armeni","year":"2022","journal-title":"Maturitas"},{"key":"R17-20260528","doi-asserted-by":"crossref","first-page":"845180","DOI":"10.4061\/2010\/845180","article-title":"Progesterone and bone: actions promoting bone health in women","volume":"2010","author":"Seifert-Klauss","year":"2010","journal-title":"J Osteoporos"},{"key":"R18-20260528","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/13697137.2018.1467400","article-title":"Progesterone for the prevention and treatment of osteoporosis in women","volume":"21","author":"Prior","year":"2018","journal-title":"Climacteric"},{"key":"R19-20260528","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fendo.2020.00603","article-title":"Hormonal contraception and bone health in adolescents","volume":"11","author":"Bachrach","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R20-20260528","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ghir.2016.09.001","article-title":"A summary of the influence of exogenous estrogen administration across the lifespan on the GH\/IGF-1 axis and implications for bone health","volume":"32","author":"Southmayd","year":"2017","journal-title":"Growth Horm IGF Res"},{"key":"R21-20260528","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jpag.2025.03.004","article-title":"Effects of combined hormonal contraceptives (CHCs) on bone health in adolescent girls-a systematic review","volume":"38","author":"Lim","year":"2025","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"R22-20260528","doi-asserted-by":"crossref","first-page":"e0285885","DOI":"10.1371\/journal.pone.0285885","article-title":"Bone impact after two years of low-dose oral contraceptive use during adolescence","volume":"18","author":"Orsolini","year":"2023","journal-title":"PLoS One"},{"key":"R23-20260528","first-page":"CD009849","article-title":"Steroidal contraceptives and bone fractures in women: evidence from observational studies","volume":"2015","author":"Lopez","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R25-20260528","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.contraception.2009.11.003","article-title":"Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections","volume":"81","author":"Harel","year":"2010","journal-title":"Contraception"},{"key":"R26-20260528","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2007.10.005","article-title":"Bone density recovery after depot medroxyprogesterone acetate injectable contraception use","volume":"77","author":"Kaunitz","year":"2008","journal-title":"Contraception"},{"key":"R27-20260528","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10654-025-01273-2","article-title":"Oral contraceptive use increases bone density and reduces the risk of osteoporosis","volume":"40","author":"Ivansson","year":"2025","journal-title":"Eur J Epidemiol"},{"key":"R28-20260528","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1007\/s00198-019-05103-6","article-title":"Bone health in estrogen-free contraception","volume":"30","author":"Hadji","year":"2019","journal-title":"Osteoporos Int"},{"key":"R30-20260528","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/joim.13557","article-title":"Systemic lupus erythematosus and cardiovascular disease","volume":"293","author":"Frosteg\u00e5rd","year":"2023","journal-title":"J Intern Med"},{"key":"R31-20260528","doi-asserted-by":"crossref","first-page":"e082801","DOI":"10.1136\/bmj-2024-082801","article-title":"Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study","volume":"388","author":"Yonis","year":"2025","journal-title":"BMJ"},{"key":"R32-20260528","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/acr.24803","article-title":"Frequency of contraception documentation in women with systemic lupus erythematosus and rheumatoid arthritis within the Rheumatology Informatics System for Effectiveness Registry","volume":"75","author":"Clowse","year":"2023","journal-title":"Arthritis Care Res"},{"key":"R33-20260528","doi-asserted-by":"crossref","first-page":"e001192","DOI":"10.1136\/lupus-2024-001192","article-title":"Alignment of contraception use with the ACR reproductive health guidelines in women with systemic lupus erythematosus within the RISE registry","volume":"11","author":"Clowse","year":"2024","journal-title":"Lupus Sci Med"},{"key":"R34-20260528","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/acr.25562","article-title":"Improving documentation rates of contraception and reproductive planning in patients with rheumatic disease","volume":"77","author":"Moon","year":"2025","journal-title":"Arthritis Care Res"},{"key":"R35-20260528","doi-asserted-by":"crossref","first-page":"e11775","DOI":"10.1002\/acr2.11775","article-title":"Increasing contraception documentation in an Academic Rheumatology Clinic: a quality improvement approach","volume":"7","author":"Siegel","year":"2025","journal-title":"ACR Open Rheumatol"},{"key":"R36-20260528","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/acr.23724","article-title":"Contraception use among reproductive-age women with rheumatic diseases","volume":"71","author":"Birru Talabi","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R37-20260528","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.contraception.2021.08.017","article-title":"Contraceptive use and counseling in patients with systemic lupus erythematosus","volume":"105","author":"Silverstein","year":"2022","journal-title":"Contraception"},{"key":"R38-20260528","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.contraception.2020.11.001","article-title":"Contraception decision-making and care among reproductive-aged women with autoimmune diseases","volume":"103","author":"Stransky","year":"2021","journal-title":"Contraception"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0000000000001162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:23:05Z","timestamp":1786040585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0000000000001162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001162","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}